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Abstract
Road accidents are among the main fatalities worldwide and drowsy driving is a significant cause of road deaths where drivers are at fault. There are 
well known diseases which impair sensory and cognitive functions and can cause sleepiness during driving. Such diseases can be an important contrain-
dication to driving because they may have an adverse effect on its safety. Thus, medical examinations for drivers should also be directed at identifying 
any possible conditions posing risks for driving safety. Occupational medicine specialists should look for symptoms of locomotor and sleep-related 
breathing disorders as these are medical conditions which could preclude a person from driving. In this case report, the authors describe a professional 
driver with chest deformity and present a pioneering attempt at assessing his medical fitness to drive. It is also explained why scoliosis can impair driv-
ing ability and how it should be diagnosed and treated. Finally, the authors describe how they used driving simulator tests as part of their diagnosis 
and suggest a relevant treatment regimen. Int J Occup Med Environ Health. 2019;32(5):735 – 45
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INTRODUCTION
It is essential to create an environment for safe transport 
for citizens around the world. In Europe, the European 
Commission (EC) is the institution which strives to pro-
vide the highest standards of road safety [1]. Road trans-
port is the most widely used means of travel and the pri-
mary reason for accidents. The European Union statistics 
show that the number of traffic-related accidents is gradu-
ally decreasing. In 2015, the number of road fatalities was 
26 000 and that is 5500 fewer than in 2010. According to 
statistics provided by the EC, as many as 135 000 people 
were severely injured during road accidents in 2016. Social 
costs (including healthcare) of road accidents resulting in 
injuries and fatalities are estimated to reach at least EUR 
100 billion. Furthermore, it has been shown that traffic-
related death rates have not fallen significantly enough in 
the past few years. In 2016, in Europe, the road fatality 
figure reached over 25 000 (Figure 1).
Main reasons for traffic-related accidents differ depend-
ing on the area of the world but excessive speed and alco-
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disorders are an important factor which increases the risk 
of road accidents [4]. These disorders include narcolepsy, 
sleep apnoea, insomnia, shift work sleep disorder, restless 
legs syndrome/Willis-Ekbom disease, periodic limb move-
ment disorder and migraine. Therefore, physicians exam-
ining professional drivers should possess basic knowledge 
that would allow them to properly diagnose the above 
syndromes. Due to the high incidence of some of these 
disorders, a number of highly-developed countries have 
issued specific legal acts, the best example of these being 
European Union Directive 2014/85/EU [5] based on ob-
structive sleep apnoea (OSA) epidemiology [6,7].
Examination standards for professional drivers also point 
out other symptoms known to have increased the risk of 
traffic-related accidents [8]. These conditions include epi-
lepsy, diabetes, cardiac problems, dementia, eyesight dis-
hol consumption still lead the rank. One of the frequent 
and statistically underrated causes of traffic-related ac-
cidents is drowsy driving [2]. As demonstrated by Gon-
calves et al. in their analysis conducted during a 2-year pe-
riod in 19 European countries, 17% of drivers experienced 
falling asleep at the wheel [3]. Among the respondents 
who fell asleep, the median prevalence of sleep-related 
accidents was 7%.
Fatigue and drowsiness result not only from sleep depri-
vation but also from health issues. Thus, the medical as-
pect of this phenomenon requires closer attention and be-
comes a serious challenge for specialists and general prac-
titioners examining their patients’ medical fitness to drive. 
The issue becomes even more significant when it comes to 
the examination and permits for professional drivers. The 
current medical knowledge confirms that sleep-related 
Figure 1. Road fatalities in the EU since 2001
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the Pulmonology Clinic for consultation on the grounds 
of protracted convalescence after an acute asthma epi-
sode in March 2016. The patient was then hospitalized 
for 3 weeks at a regional internal medicine ward. On ad-
mission to the Clinic, the patient complained of permanent 
weakness, worse physical exercise tolerance and frequent 
sleepiness. The treatment introduced included fluticasone 
propionate, 500 μg and salmeterol, 50 μg; theophylline 
300 mg/day as well as ipratropium with phenoterol admin-
istered 3 times/day in nebulization.
Several years ago, the patient had been operated for ky-
phoscoliosis. No comorbidities were found in the patient 
apart from asthma. The patient was a professional long-
distance truck driver travelling for business purposes to 
several European destinations. Despite a visible musculo-
skeletal deformation, he demonstrated a very good work 
report and his job constituted an important part of his life 
as well as a source of personal satisfaction.
The main (and only) abnormality found in the patient dur-
ing physical examination was a major chest deformation. 
The patient’s arterial blood oxygen saturation measured 
with pulse oximetry on air breathing was 94%. A chest 
X-ray was then performed in 2 projections (Figures 2 
and 3) and arterial blood gasometry (Table 1).
eases, schizophrenia and others. However, little is being 
said about musculoskeletal impairments which arise from 
numerous disorders and trauma like, for instance, amputa-
tions, deformities as well as chronic lower back pain. They 
can impair movement or sensation and affect balance, co-
ordination or power. There is extremely little published 
data on the risk of road accidents resulting from muscu-
loskeletal disorders [9]. Although several studies refer to 
patients with an impaired musculoskeletal system who ex-
perienced driving difficulties, only a few suggest that these 
disorders increase the accident risk [10]. This may be due 
to the fact that drivers are able to compensate for physi-
cal impairments while driving. Although chest deformities 
are quite frequent, their effect on fitness to drive has not 
been examined in literature to date. Adolescent idiopathic 
scoliosis (the most frequent form of defect) is a common 
disease with an overall prevalence of 0.47–5.2% in the cur-
rent literature [11].
This article is a case study of a 26-year old professional 
long-distance truck driver with adolescent idiopathic sco-
liosis, suffering from hypoventilation and mild sleep ap-
noea. The main symptoms reported by the patient were 
a reduced ability to exercise and frequent sleepiness. 
The patient had undergone a surgical treatment to stop 
the progression of spine deformity but on admission still 
showed a considerable degree of scoliosis. The patient’s 
symptoms were proven to be the effect of kyphoscoliosis 
and the patient was consequently subjected to continuous 
non-invasive ventilation (NIV) treatment. The aim of this 
case study is to bring attention to the diagnosis of persons 
with chest deformities applying for a driving license. The 
authors also aim at presenting the necessity of introducing 
a scheme to identify the scale and effects of the analyzed 
disorder.
CASE REPORT
In June 2016, a 26-year old patient with advanced kypho-
scoliosis and diagnosed bronchial asthma was referred to 
Figure 2. Chest X-ray in PA projection: visible significant 
scoliosis of the spine and an implant stabilizing it
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Spirometry (Table 2) showed reversible obturation, sig-
nificantly lowered forced vital capacity (FVC), 26% of the 
predictive value.
Suspected restriction was confirmed in whole-body air dis-
placement cabin plethysmography (Table 3).
Diffusing capacity of the lung for the carbon monoxide 
test (lung transfer factor for carbon monoxide – TLCO) 
showed lowered total lung capacity (single breath TLCO – 
TLCOSB 39.8% p.v.) with the correct value per alveolar 
volume (diffusing capacity for carbon monoxide corrected 
for hemoglobin level per unit alveolar volume – TLCOc/VA 
103%) (Table 4).
During polysomnography (Tables 5 and 6) only few episodes 
of sleep apnoea and hypopnea were found. The apnoea-
hypopnea index (AHI) factor was as low as 6.4/h, but seri-
ous deteriorations were found in nocturnal blood oxygen-
ation and blood carbon dioxide level. In accordance with the 
American Academy of Sleep Medicine (AASM) criteria, 
hypoventilation syndrome was diagnosed [12]. Furthermore, 
arterial blood gasometry taken at 2 a.m. showed deepening 
hypoxia and hypercapnia (Table 1). Alveolar hypoventila-
tion was diagnosed as the effect of thoracic cage disorder.
Echocardiography and comprehensive blood tests did 
not show further disorders. The asthma diagnosis was 
sustained and the disease was assessed as fully controlled 
with the asthma control test (ACT) [13] score of 23. Medi-
cation was limited to fluticasone propionate, 500 μg and 
In view of the abnormal gasometry the patient with sus-
pected hypoventilation was referred for further diagnos-
tics to the Pulmonology Clinic. At the Clinic, the patient 
underwent further diagnostics, i.e., comprehensive blood 
panel testing, appropriate lung function tests and poly-
somnography with capnography and arterial blood gas 
monitoring during sleep, as well as echocardiography.
Figure 3. Chest X-ray in left lateral projection: in addition to 
the deformation and the implant, the correct lung hilum and 
the normal lung parenchyma are visible
Table 1. Arterial blood gasometry during the day and night before treatment and during non-invasive ventilation treatment  
in a professional driver with advanced kyphoscoliosis and bronchial asthma in the Pulmonology Clinic in 2016
Parameter
Test result
the day before treatment the night before treatment during non-invasive ventilation treatment
pH 7.39 7.34 7.41
pCO2 [mm Hg] 48.2 61.9 46.0
pO2 [mm Hg] 68 59 71
SO2 [%] 94.4 90.5 95.6
HCO3– [mmol/l] 27.3 29.8 26.4
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be issued by an occupational health professional but the 
pulmonologist in charge had to deliver his opinion as to 
the completion of the treatment and its final effectiveness. 
The sleepiness level score assessed using the Epworth 
scale was 3 pts (normal) [14]. Sleep quality assessed with 
the Pittsburgh Sleep Quality Index was also deemed good, 
salmeterol, 50 μg and rescue medication (salbutamol) in 
the case of dyspnoea.
Since the patient was diagnosed with hypoventilation, 
NIV therapy was introduced. Two full-night attended po-
lysomnographies were performed for titration to deter-
mine the optimal positive airway pressure.
Finally, sleep tests confirmed full normalization of sleep 
disturbances, which was achieved through bi-level ven-
tilation with average volume assured pressure support 
(AVAPS): inspiratory positive airway pressure (IPAP) 
17 mbar, maximal inspiratory positive airway pressure 
(IPAPmax) 22 mbar, tidal volume (Vt) 400 ml, expiratory 
positive airway pressure (EPAP) 6 mbar, breaths per minute 
(BPM) 15/min, and inspiratory time (Ti) 1.2 s. Ventilation was 
recommended for at least 8 h/day and always during sleep. 
The patient was advised to continue the treatment at home.
It was necessary to assess the patient’s ability to continue 
work in view of his occupation. The final decision was to 
Table 2. Spirometry with bronchodilator (BD) reversibility test in a professional driver with advanced kyphoscoliosis and bronchial 




actual % predicted actual % change
FEV1 [l] 0.85 20.9 0.98 3.2
FVC [l] 1.27 26.6 1.25 –0.5
FEV1%FVC 66.72 78.55
FEV1 – forced expiratory volume in the first second of expiration; FVC – forced vital capacity.
Table 3. Whole-body air displacement cabin plethysmography in a professional driver with advanced kyphoscoliosis and bronchial 
asthma in the Pulmonology Clinic in 2016
Variable
Whole-body cabin plethysmography results
actual % predicted percentile
RV [l] 1.37 86 28
VC [l] 1.43 29 < 0.01
TLC [l] 2.8 43 0.01
RV – residual volume; TLC – total lung capacity; VC – vital capacity.
Table 4. Transfer factor for carbon monoxide in a professional 
driver with advanced kyphoscoliosis and bronchial asthma  
in the Pulmonology Clinic in 2016
Parameter
Carbon monoxide transfer 
factor results
actual % predicted
TLCOSB [mmol/min/kPa] 4.3 38.6
TLCOcSB [mmol/min/kPa] 4.44 39.8
TLCOc/VA [mmol/min/kPa/l] 1.76 103
TLCO – lung transfer factor for carbon monoxide; TLCOc/VA – diffusing 
capacity for carbon monoxide corrected for the hemoglobin level per 
unit alveolar volume; SB – single breath.
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The patient was subjected to check-up sleep diagnosis con-
sisting of capnometry and arterial blood gasometry which 
showed that all symptoms were under control as a result of 
NIV. Nonetheless, the situation of the patient still seemed 
unclear, unlike, e.g., in the case of a patient with simple 
apnoea treated with continuous positive airway pressure 
(CPAP) who could have been recommended to resume 
working as a driver. For this reason, advice was sought 
from occupational health professionals who recommend-
ed that the patient take a truck drive simulator test which 
would reflect his driving ability. The test consisted of city 
driving, driving on country roads and in the mountains 
during moderate traffic. The simulation showed differ-
showing a score of 3 [15]. However, the above results were 
not sufficient for the pulmonologist in charge who was un-
sure as to what extent the patient’s condition could affect 
his cognitive ability. Consequently, the patient was sent on 
a further sick leave, and was to present for check-up and 
sleep tests in 6 weeks. The patient felt well while on the 
sick leave. During the check-up, the respirator memory 
card was read and analyzed. The patient’s compliance with 
therapy was confirmed and so was the positive therapeutic 
outcome: there were no breathing disorders during sleep 
(AHI 2.4/h) and ventilation was smooth. The mean maxi-
mal expiratory volume (tidal volume expiration maximal – 
VTemax) was 497 ml.
Table 5. Polysomnography report – an excerpt (saturation values) in a professional driver with advanced kyphoscoliosis and bronchial 
asthma in the Pulmonology Clinic in 2016
Parameter
Blood oxygen saturation
awake NREM REM TIB
Desaturations [n] 0 54 11 65
Index [1/h] 0.0 40.5 42.0 40.8
Average SpO2% 87 84 91 86
NREM – non-rapid eye movement; REM – rapid eye movement; TIB – time in bed
Table 6. Patients’ polysomnography report – an excerpt (saturation sections) in a professional driver with advanced kyphoscoliosis 






awake NREM REM TST
min % min % min % min %
< 95% 7.4 2.3 80.0 25.2 15.7 5.0 103.1 32.5
< 90% 7.4 2.3 68.5 21.6 1.8 0.6 77.7 24.5
< 85% 0.6 0.2 19.1 6.0 0.0 0.0 19.7 6.2
< 80% 0.0 0.0 16.0 5.0 0.0 0.0 16.0 5.0
< 75% 0.0 0.0 10.4 3.3 0.0 0.0 10.4 3.3
< 70% 0.0 0.0 5.8 1.8 0.0 0.0 5.8 1.8
< 60% 0.0 0.0 0.3 0.1 0.0 0.0 0.3 0.1
< 50% 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
NREM – non-rapid eye movement; REM – rapid eye movement; TST – total sleep time.
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a diagnosis of the lung function based on blood oxygen 
saturation only can be misleading. The authors describe 
the treatment introduced and present a pioneering ap-
proach towards the medical approval of a driving permit 
for professional drivers who require NIV therapy. Finally, 
they also prove that some patients undergoing NIV can 
have an active professional life and continue driving.
Among the reasons behind driving restrictions connected 
with musculoskeletal deformations, hypoventilation in driv-
ers has been previously overlooked. The medical standards 
for driving permits also do not mention a higher incidence 
of sleep apnoeas resulting from kyphoscoliosis. However, al-
ready at the turn of the 1970s, some studies mentioned that 
musculoskeletal deformations could be predictors of sleep 
breathing disorders [16,17]. Guilleminault et al. described 
a possibility of several sleep breathing disorders in subjects 
with severe chest deformation and called it the Quasimodo 
syndrome during sleep [18]. Further studies confirmed how 
important it was to look for and treat sleep breathing issues 
such as apnoeas and hypoventilation in patients suffering 
from kyphoscoliosis, chronic obstructive pulmonary disease 
(COPD) or neuromuscular disorders [19]. It is also known 
that sleep disorders such as apnoeas and alveolar hypoven-
tilation can impair concentration, thus becoming a risk fac-
tor for a road traffic accident [4,20,21].
Initial stages of hypoventilation with mild to moderate hy-
percapnia are usually asymptomatic or show only minimal 
symptoms. Patients may complain of anxiety and dyspnoea 
ent weather conditions: summer, winter, strong wind and 
heavy rain. The test also incorporated stressful situations 
such as cutting off by another vehicle (at a roundabout), 
driving on narrow streets and sudden steering wheel jerk. 
The simulation included a manual and automatic gearbox. 
Furthermore, the patient’s ability (skill) to start the en-
gine, switch on the lights, indicators and other controls on 
the steering column was tested. The study time was 40 min. 
The study protocol included driving on easy and difficult 
routes, and provided situations requiring a fast driver’s 
reaction. Figure 4 shows AUTOSAN LIDER 1010T bus 
simulator and a view of the operator station.
An actual bus cabin is mounted on a movable platform, 
simulating the movements of the bus under real-world con-
ditions. The visualization system of the simulator generates 
and displays a realistic view as seen from the cabin of the ve-
hicle. This allows the examined driver to see the road and its 
environment in a manner similar to the real circumstances.
The result of the test did not provide any argument against 
the patient resuming his professional activity. Since the 
patient was recommended to use the respirator every 
night and as this would be rather difficult to achieve for 
a long-distance driver, he was advised to drive only on 
short routes so that he would be able to spend nights at 
home and use the device. This has discouraged the pa-
tient from resuming work as a driver. He is now working 
in a restaurant and considering becoming a courier so that 
he can drive more again.
DISCUSSION
The present case study is the first, to the best of the au-
thors’ knowledge, that refers to a professional long-dis-
tance driver suffering from kyphoscoliosis resulting in 
hypoventilation and sleep-related breathing disorders. 
This is also the first instance when a driving simulator was 
used to assess the ability to drive vehicles in a patient with 
scoliosis. This study presents the patient’s imaging and 
breathing function test results. The study also shows that 
Photo: Zbigniew Jóźwiak
Figure 4. AUTOSAN LIDER 1010T bus simulator
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apnoea, and > 120° is directly related to hypoventilation 
and respiratory failure [25]. In the patient under analysis, 
the Cobb angle was 140°. The basic spirometry test is an-
other valuable tool that allows estimating the risk of respi-
ratory failure. A vital capacity (VC) score < 43% is a sig-
nificant predictor of respiratory failure [26]. This patient’s 
FVC score was only 26%.
A full polysomnography is the best test to detect night hy-
poventilation. In accordance with the AASM guidelines, the 
key parameter here is the CO2 level measurement [12]. Dur-
ing the REM sleep phase, patients usually experience the 
most acute hypoventilation. When trying to determine the 
reasons for this problem, the authors noticed that the REM 
phase in the patient under analysis was rather short. Before 
one of the REMs, the patient woke up and stayed awake for 
about 20 min so that his oxygenation could improve (cap-
nia was reduced). Then, he fell asleep and easily went into 
REM. This reserve is hence one of the mechanisms which 
could explain his good saturation throughout the REM. 
The following REM was typical but short. Therefore, the 
patient’s results may be misleading if only the mean values 
are considered. The decision to implement NIV treatment 
resulted from the authors’ factual knowledge.
It is known that no other respiratory failure treatment 
method in kyphoscoliosis is more effective than NIV [27]. 
Such treatment in patients with kyphoscoliosis not only in-
creases the survival rate [28], but also improves gasometry, 
reduces hypoventilation symptoms and has a beneficial im-
pact on muscle function [29]. It is a good clinical practice to 
confirm the treatment efficacy in a control sleep test [30].
There are several scales and questionnaires used to pre-
dict the risks or evaluate the degree of symptoms con-
nected with sleep apnoea [31]. Nonetheless, little is known 
as far as their efficacy in reference to hypoventilation is 
concerned. For this reason, a decision to issue a driving 
permit to patients with hypoventilation becomes more 
difficult. The authors decided to use an advanced driving 
simulator as a diagnostic tool because they wanted to en-
with exertion. With an increase in the degree of hypoven-
tilation, they develop dyspnoea at rest. Some may experi-
ence disturbed sleep and daytime hypersomnolence while 
others may further develop increased hypercapnia and hy-
poxemia. It is important to emphasize that most patients 
develop hyperventilation during night and only later expe-
rience symptoms during daytime [22]. Such a situation can 
initially affect mainly the structure of sleep and impair its 
quality. This pathomechanism may be of key importance 
in increasing the risk of falling asleep while driving.
The patient studied showed typical hypoventilation symp-
toms, and his tiredness as well as muscular weakness were 
wrongly interpreted as asthma exacerbation-related prob-
lems. Probably the viral infection which led to asthma exac-
erbation became a mechanism which triggered off earlier 
mild hypoventilation. Also, transcutaneous blood oxygen 
saturation measurement could have been misleading here 
because the 94% result could wrongly suggest that the pa-
tient experienced no lung function impairment. It is worth 
to point out here that even an arterial blood saturation 
test does not fully correlate with partial pressure of oxy-
gen [23]. Thus, an arterial blood gasometry test was a cru-
cial diagnostic decision because it confirmed hypercapnia 
and consequent hypoxemia. The result of the test showed 
an increased HCO3– value which was caused by meta-
bolic compensation of breathing acidosis resulting from 
hypoventilation. The level of HCO3– is a good parameter 
for judging the risk of hypoventilation. This observation 
is known mainly from hypoventilation analyses in obese 
subjects [24]. It is assumed that a HCO3– > 27 mmol/l 
significantly increases the probability of hypoventilation. 
This patient’s result was HCO3– = 27.3 mmol/l.
There are known cases in literature which show how to 
look for hypoventilation risks and lung function impair-
ment resulting from kyphoscoliosis. One of these is the 
Cobb angle – a measure that describes the degree of spinal 
deformation [16]. It is assumed that a Cobb angle value 
> 70° significantly reduces lung area, > 100° results in 
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CONCLUSIONS
A patient with kyphoscoliosis can suffer from hypoven-
tilation and sleep breathing disorders. Hypoventilation 
and/or sleep apnoeas in kyphoscoliosis can be considered 
a contraindication to driving vehicles. Therefore, persons 
with significant scoliosis and accompanying breathing dis-
orders, when applying for a medical certificate for drivers, 
should be consulted by specialists in this type of illness. 
In the case of a high degree of scoliosis, low spirometric 
values or clinical signs of breathing disorders during sleep, 
patients should be referred to pulmonologists in order to 
exclude hypoventilation and apnoeas during sleep. To this 
end, it is necessary to implement a full specialist diagnosis 
including polysomnography and capnometry. This knowl-
edge should be publicized among physicians responsible 
for assessing their patients’ medical fitness to drive. Con-
firmed hypoventilation in kyphoscoliosis is an indication 
to implement NIV treatment. An efficiently treated and 
controlled hypoventilation can allow the patient to func-
tion and work normally. The specificity of NIV treatment, 
however, does not enable treatment outside patients’ 
home environment.
The use of simulator tests in the diagnostic process can sig-
nificantly improve not only the driver evaluation scheme 
but also the specialist assessment of the patients’ ability 
to drive. The availability of this method is still limited but 
it can be helpful to occupational medicine specialists in 
diagnosing specific cases of patients whose ability to drive 
cannot be assessed in other tests.
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